Sulin Zhang

机构：Union Hospital, Chinese Academy of Sciences, Chinese Academy of Engineering, Shanghai Institute of Materia Medica, Drug Discovery Laboratory (Norway), Institute for Advanced Study, University of Chinese Academy of Sciences, Huazhong University of Science and Technology

发表论文 80 篇 · 总被引 1612 次 · h-index 23

代表论文

• A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers (2025 · Cancer Cell · 被引 30)
• Methotrexate exerts antitumor immune activity and improves the clinical efficacy of immunotherapy in patients with solid tumors (2025 · Science Translational Medicine · 被引 20)
• Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer (2025 · Nature Cancer · 被引 11)
• Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor Activity (2025 · Journal of Medicinal Chemistry · 被引 5)
• Discovery of novel covalent stabilizers for p53 Y220C using structure-based drug discovery methods (2025 · Molecular Diversity · 被引 4)
• Mechanistic Insights into the Allosteric Regulation of P53 Y220C by Small-Molecule Stabilizers (2025 · Journal of Chemical Information and Modeling · 被引 3)